RAASi therapy made practical: A unified call to action and a ready-to-use clinical toolkit
“Optimization of renin-angiotensin-aldosterone inhibitor therapies for evidence-based indications: A call to action from the cardio-kidney community,” a new joint commentary led by the ISN and partnering organizations, has been published in Kidney International Reports®, the American Journal of Preventive Cardiology, and ESC Heart Failure. Read the full commentary Although essential for managing chronic kidney disease, heart...
